BMRN
BioMarin Pharmaceutical Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #809
- Final score
- 29.34
- Years on list
- 7
↘ Down 160 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 160 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 226 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 34 since 2023
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | BMRN | JAZZ | MEDP |
|---|---|---|---|
| Climate Change | 24.0 | 27.8 | 34.8 |
| Employee Relations | 34.5 | 36.8 | 35.2 |
| Environment | 20.4 | 17.5 | 13.4 |
| Stakeholders & Society | 29.8 | 51.3 | 18.3 |
| Human Rights | 27.2 | 9.7 | 21.6 |
| Governance | 36.5 | 33.0 | 40.3 |
| Performance Rating | 59.3 | 51.0 | 48.4 |